European Organization for Research and Treatment of Cancer
53 articles about European Organization for Research and Treatment of Cancer
-
AVEO Pharmaceuticals, Inc.'s Tivozanib in Combination with FOLFOX6 Demonstrates Anti-tumor Activity and Safety in Advanced GI Cancers; Results Presented at European Organization for Research and Treatment of Cancer-National Cancer Institute-American Assoc
11/18/2010
-
Enzon Pharmaceuticals, Inc. Presents Data at 2010 Enzon Pharmaceuticals, Inc.-European Organization for Research and Treatment of Cancer-National Cancer Institute Meeting
11/17/2010
-
4SC AG to Highlight the Potential of Its Oncology Compounds at the 22nd 4SC AG-European Organization for Research and Treatment of Cancer-National Cancer Institute Symposium 'on Molecular Targets and Cancer Therapeutics'
11/16/2010
-
SuperGen, Inc. Pipeline Presentations at SuperGen, Inc.-European Organization for Research and Treatment of Cancer-National Cancer Institute
11/15/2010
-
Curis, Inc. to Present CUDC-101 Phase I Clinical Data and CU-201 Preclinical Data at the 22nd European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium
11/15/2010
-
Cerulean Pharma Inc. to Present at BIO-Europe and European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research
11/11/2010
-
ImmunoGen, Inc. Announces Presentations at the 22nd ImmunoGen, Inc.-European Organization for Research and Treatment of Cancer-National Cancer Institute Symposium on Molecular Targets and Cancer Therapeutics
11/2/2010
-
Abstracts Highlighting Data from Enzon Pharmaceuticals, Inc.'s mRNA Antagonist Programs Accepted for Presentation at 2010 European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Meeting
10/29/2010
-
Zalicus Inc. (Formerly Known as CombinatoRx, Incorporated) Presents Data on Oncology Research at American Society of Clinical Oncology-National Cancer Institute-European Organization for Research and Treatment of Cancer Meeting
10/19/2010
-
Gemin X Pharmaceuticals, Inc. Announces Data Presentations for its Novel, Targeted Cancer Therapies Obatoclax and GMX1777 at the 20th Annual EORTC-NCI-AACR Symposium
10/16/2008
-
Exelixis, Inc. Will Have 15 Presentations at the 2008 EORTC-NCI-AACR Annual Meeting
10/16/2008
-
Cytokinetics, Inc. Announces Preclinical Data for GSK-923295 to Be Presented at the 2007 AACR-NCI-EORTC International Conference
10/17/2007
-
European Organization for Research and Treatment of Cancer And FDA Extend Drug-Label Based On Results Of The European Medicines Evaluation Agency 24971 Trial
10/20/2006